{"id":"https://openalex.org/W2042437495","doi":"https://doi.org/10.1111/j.1600-0447.1991.tb05579.x","title":"Double\u2010blind comparative multicentre study of fluvoxamine and mianserin in the treatment of major depressive episode in elderly people","display_name":"Double\u2010blind comparative multicentre study of fluvoxamine and mianserin in the treatment of major depressive episode in elderly people","alternate_titles":[],"publication_year":1991,"publication_date":"1991-06-01","ids":{"openalex":"https://openalex.org/W2042437495","doi":"https://doi.org/10.1111/j.1600-0447.1991.tb05579.x","mag":"2042437495","pmid":"https://pubmed.ncbi.nlm.nih.gov/1909083"},"language":"en","primary_location":{"id":"doi:10.1111/j.1600-0447.1991.tb05579.x","doi":"https://doi.org/10.1111/j.1600-0447.1991.tb05579.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1600-0447.1991.tb05579.x","pdf_url":null,"source":{"id":"https://openalex.org/S199498439","display_name":"Acta Psychiatrica Scandinavica","issn_l":"0001-690X","issn":["0001-690X","1600-0447"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Psychiatrica Scandinavica","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2042437495"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031440697","display_name":"A. L. Phanjoo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801618995","display_name":"Royal Edinburgh Hospital","ror":"https://ror.org/04jxcef68","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1324252669","https://openalex.org/I2801618995"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"A. L. Phanjoo","raw_affiliation_strings":["Jardine Clinic, Royal Edinburgh Hospital, Scotland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jardine Clinic, Royal Edinburgh Hospital, Scotland","institution_ids":["https://openalex.org/I2801618995"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025249043","display_name":"Susan Wonnacott","orcid":"https://orcid.org/0000-0002-3775-7563","observed_orcids":["https://orcid.org/0000-0002-3775-7563"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Wonnacott","raw_affiliation_strings":["Medical Department, Duphar Laboratories Limited, Southampton, Hampshire, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Department, Duphar Laboratories Limited, Southampton, Hampshire, United Kingdom","institution_ids":[]}]},{"author_position":"last","author":{"id":null,"display_name":"A. Hodgson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Hodgson","raw_affiliation_strings":["Medical Department, Duphar Laboratories Limited, Southampton, Hampshire, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Department, Duphar Laboratories Limited, Southampton, Hampshire, United Kingdom","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5031440697"],"corresponding_institution_ids":["https://openalex.org/I2801618995"],"apc_list":{"value":4880,"currency":"USD","value_usd":4880},"apc_paid":null,"fwci":2.7573,"has_fulltext":false,"cited_by_count":51,"citation_normalized_percentile":{"value":0.89341439,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"83","issue":"6","first_page":"476","last_page":"479"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10272","display_name":"Mental Health Treatment and Access","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fluvoxamine","display_name":"fluvoxamine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/mianserin","display_name":"mianserin","score":1.0},{"id":"https://openalex.org/keywords/major-depressive-episode","display_name":"major depressive episode","score":0.9559999704360962},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.9350000023841858},{"id":"https://openalex.org/keywords/antidepressant-comparison","display_name":"antidepressant comparison","score":0.6600000262260437},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.6169999837875366},{"id":"https://openalex.org/keywords/drug-intolerance","display_name":"drug intolerance","score":0.5619999766349792},{"id":"https://openalex.org/keywords/nausea-and-vomiting","display_name":"nausea and vomiting","score":0.8569999933242798},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.5989999771118164},{"id":"https://openalex.org/keywords/montgomery-asberg-depression-rating-scale","display_name":"Montgomery-Asberg Depression Rating Scale","score":0.7490000128746033}],"concepts":[{"id":"https://openalex.org/C2779910183","wikidata":"https://www.wikidata.org/wiki/Q409236","display_name":"Fluvoxamine","level":5,"score":0.9632115960121155},{"id":"https://openalex.org/C2780831388","wikidata":"https://www.wikidata.org/wiki/Q416701","display_name":"Mianserin","level":4,"score":0.8972355127334595},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.7440659999847412},{"id":"https://openalex.org/C2776867660","wikidata":"https://www.wikidata.org/wiki/Q1814941","display_name":"Depression (economics)","level":2,"score":0.6063122749328613},{"id":"https://openalex.org/C2780852908","wikidata":"https://www.wikidata.org/wiki/Q127076","display_name":"Vomiting","level":2,"score":0.5972989201545715},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4716944992542267},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4432523250579834},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.42935553193092346},{"id":"https://openalex.org/C2781210005","wikidata":"https://www.wikidata.org/wiki/Q6738337","display_name":"Major depressive episode","level":3,"score":0.42537885904312134},{"id":"https://openalex.org/C3019858935","wikidata":"https://www.wikidata.org/wiki/Q4340209","display_name":"Depressive symptoms","level":3,"score":0.41922783851623535},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3907232880592346},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.3895975947380066},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.37658506631851196},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.10598757863044739},{"id":"https://openalex.org/C2776134451","wikidata":"https://www.wikidata.org/wiki/Q422244","display_name":"Fluoxetine","level":4,"score":0.07762551307678223},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.05492633581161499},{"id":"https://openalex.org/C2780733359","wikidata":"https://www.wikidata.org/wiki/Q331769","display_name":"Mood","level":2,"score":0.040011078119277954},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C139719470","wikidata":"https://www.wikidata.org/wiki/Q39680","display_name":"Macroeconomics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D003866","descriptor_name":"Depressive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003866","descriptor_name":"Depressive Disorder","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006760","descriptor_name":"Hospitalization","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008803","descriptor_name":"Mianserin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008803","descriptor_name":"Mianserin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D010091","descriptor_name":"Oximes","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010091","descriptor_name":"Oximes","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016666","descriptor_name":"Fluvoxamine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1600-0447.1991.tb05579.x","doi":"https://doi.org/10.1111/j.1600-0447.1991.tb05579.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1600-0447.1991.tb05579.x","pdf_url":null,"source":{"id":"https://openalex.org/S199498439","display_name":"Acta Psychiatrica Scandinavica","issn_l":"0001-690X","issn":["0001-690X","1600-0447"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Psychiatrica Scandinavica","raw_type":"journal-article"},{"id":"pmid:1909083","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1909083","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta psychiatrica Scandinavica","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":18,"referenced_works":["https://openalex.org/W1981628559","https://openalex.org/W1982955144","https://openalex.org/W2001214750","https://openalex.org/W2004568218","https://openalex.org/W2014001995","https://openalex.org/W2023163409","https://openalex.org/W2028094236","https://openalex.org/W2032884131","https://openalex.org/W2037557778","https://openalex.org/W2057304170","https://openalex.org/W2059907720","https://openalex.org/W2064500615","https://openalex.org/W2072661188","https://openalex.org/W2099063755","https://openalex.org/W2112519660","https://openalex.org/W2131823335","https://openalex.org/W3128184755","https://openalex.org/W4246773810"],"related_works":["https://openalex.org/W1964115588","https://openalex.org/W4367594173","https://openalex.org/W4243033828","https://openalex.org/W2054886685","https://openalex.org/W2295918339","https://openalex.org/W2360266499","https://openalex.org/W2091914029","https://openalex.org/W1999122580","https://openalex.org/W2013806261"],"abstract_inverted_index":{"This":[0],"is":[1],"a":[2],"multicentre":[3],"double-blind":[4],"study":[5],"of":[6,13,22,74,93],"fluvoxamine":[7,28,63,109],"versus":[8],"mianserin":[9,33,69],"in":[10,17,43,61,67,82,115],"the":[11,46,53,62,68,91,96,108],"treatment":[12,48,72],"major":[14],"depressive":[15],"episode":[16],"patients":[18,25,59],"over":[19],"65":[20],"years":[21],"age.":[23],"Fifty-seven":[24],"received":[26],"either":[27,86],"(100-200":[29],"mg":[30,35],"daily)":[31],"or":[32],"(40-80":[34],"daily).":[36],"There":[37],"was":[38,100,110],"no":[39],"statistically":[40,77],"significant":[41,78],"difference":[42],"improvement":[44],"between":[45],"2":[47],"groups":[49],"as":[50],"measured":[51],"by":[52],"Montgomery-Asberg":[54],"Depression":[55],"Rating":[56],"Scale.":[57],"Eleven":[58],"(7":[60],"group":[64],"and":[65,119],"4":[66],"group)":[70],"discontinued":[71],"because":[73],"intolerance.":[75],"No":[76],"differences":[79],"were":[80,121],"seen":[81],"biological":[83],"parameters":[84],"with":[85],"drug.":[87],"Both":[88],"drugs":[89],"improved":[90],"symptoms":[92],"depression":[94],"though":[95],"overall":[97],"response":[98],"rate":[99],"not":[101,122],"outstanding.":[102],"The":[103],"side":[104],"effects":[105],"profile":[106],"for":[107],"contrary":[111],"to":[112],"previous":[113],"studies":[114],"that":[116],"frequent":[117],"nausea":[118],"vomiting":[120],"seen.":[123]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2042437495","counts_by_year":[{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
